About MobileODT
MobileODT is a company based in Tel Aviv (Israel) founded in 2012 was acquired by Liger Medical in August 2022.. MobileODT has raised $10.85 million across 11 funding rounds from investors including HHS, Tristel and Orbimed. MobileODT operates in a competitive market with competitors including Guided Therapeutics, Illumigyn, Mobidiag, Zilico and Biop Medical, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.85 M (USD)
in 11 rounds
-
Latest Funding Round
$2.3 M (USD), Grant
Jan 29, 2021
-
Investors
HHS
& 11 more
-
Employee Count
Employee Count
-
Acquired by
Liger Medical
(Aug 01, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of MobileODT
MobileODT has successfully raised a total of $10.85M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $2.3 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Grant — $2.3M
-
First Round
First Round
(02 Jan 2014)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Grant - MobileODT | Valuation |
investors |
|
| Aug, 2020 | Amount | Series C - MobileODT | Valuation | Orbimed | |
| Jul, 2020 | Amount | Grant - MobileODT | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MobileODT
MobileODT has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Tristel and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in disruptive health technologies for life-saving impact.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MobileODT
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MobileODT
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mobileodt Comparisons
Competitors of MobileODT
MobileODT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guided Therapeutics, Illumigyn, Mobidiag, Zilico and Biop Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Light-based devices for cervical cancer diagnostics are developed.
|
|
| domain | founded_year | HQ Location |
Colonoscope for cervical cancer detection procedures is developed.
|
|
| domain | founded_year | HQ Location |
In vitro diagnostics for infectious diseases are developed and provided.
|
|
| domain | founded_year | HQ Location |
Real-time cancer diagnostics via Electrical Impedance Spectroscopy are developed.
|
|
| domain | founded_year | HQ Location |
Point-of-care diagnostics for cervical cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mobileodt
Frequently Asked Questions about MobileODT
When was MobileODT founded?
MobileODT was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is MobileODT located?
MobileODT is headquartered in Tel Aviv, Israel.
Is MobileODT a funded company?
MobileODT is a funded company, having raised a total of $10.85M across 11 funding rounds to date. The company's 1st funding round was a Grant of $1.58M, raised on Jan 02, 2014.
What does MobileODT do?
MobileODT is focussed on developing artificially intelligent visual diagnostic tools for cancer screening. It has developed the EVA (Enhanced Visual Assessment) System which is a mobile colposcope equipped with a light source and magnification lens for the enhanced cervical visualization. It also has a secure application for patient image and data capture that enables remote consultation, patient tracking, and referral coordination. It claims that the technology can be extended to any digital camera. It is planning to expand the capabilities to identify skin and oral cancer, among other diseases that can be imaged optically.
Who are the top competitors of MobileODT?
MobileODT's top competitors include Periwinkle Technologies, Guided Therapeutics and Mobidiag.
Who are MobileODT's investors?
MobileODT has 12 investors. Key investors include HHS, Tristel, Orbimed, National Cancer Institute, and DAI.